đź’ŠWill INS018_055 be FDA-approved by 2030?
Basic
3
Ṁ472030
48%
chance
1D
1W
1M
ALL
Insilico Medicine's AI-designed drug for idiopathic pulmonary fibrosis, INS018_055, has entered Phase II clinical trials. Will it become (one of) the first AI-designed drugs to get FDA approval?
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
45% chance
Will AOH1996 be FDA approved before 2040?
44% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
66% chance
Will a vaccine for HIV be approved by the FDA by 2030?
67% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
29% chance
Will an AI-designed drug get FDA approval by the end of 2025?
30% chance
Will FDA approve an “AI doctor” for primary care before 2030?
30% chance
The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
24% chance
Which of these protein targets will have at least one new drug targeting them receive FDA approval between 2025 and 2030
Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
74% chance